BridgeMD
New treatment option for Pancreatoduodenectomy
Official title Continous Infusion of Nefopam for Patients Undergoing Pancreatoduodenectomy
ClinicalTrials.gov ID: NCT07423650
What this study is testing
What is Nefopam 120mg/day infusion?
Nefopam 120mg/day infusion is an investigational medicine, given as an infusion into a vein, being studied as a potential treatment for pancreatoduodenectomy.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The goal of this clinical trial is to determine whether continuous nefopam administration, as part of a multimodal analgesia strategy, reduces opioid consumption and improves patient satisfaction after pancreatoduodenectomy. The main questions are: Does nefopam administration reduce opioid consumption after pancreatoduodenectomy?
- Phase 4: studies an already-approved treatment
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80
You may be able to join if
- Patients scheduled for elective pancreatoduodenectomy surgery
- Agreed to participate in the study
You likely can't join if
- Refusal to participate
- Emergency surgery
- Patients with neurological disorders or other muscular or psychiatric disorders that impede communication
- Known allergic reactions to the used medication
- Known hyperalgesia
- Chronic opioid consumption
See the full eligibility criteria
- Patients scheduled for elective pancreatoduodenectomy surgery
- Agreed to participate in the study
- Refusal to participate
- Emergency surgery
- Patients with neurological disorders or other muscular or psychiatric disorders that impede communication
- Known allergic reactions to the used medication
- Known hyperalgesia
- Chronic opioid consumption
- Patients that require reintervention in the first 48h postoperatively
- Patients with pancreaticogastrostomy
The study team makes the final eligibility decision.
Where it's taking place
- Cluj-Napoca, Cluj, Romania
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Cluj-Napoca, Cluj, Romania. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.